Luteolin inhibits hyperglycemia-induced epithelial–mesenchymal transition and malignant progression in gastric cancer via targeting AKR1B1-mediated glucose metabolism

Clinical and Experimental Metastasis · Published 2026-07-14 · DOI 10.1007/s10585-026-10418-w

Authors (5)

Qin He, Feibao Tao, Xiaowen Wen, Liang Zhu, Xuxing Ye

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

He, Q., Tao, F., Wen, X., et al. (2026). Luteolin inhibits hyperglycemia-induced epithelial–mesenchymal transition and malignant progression in gastric cancer via targeting AKR1B1-mediated glucose metabolism. Clinical and Experimental Metastasis. https://doi.org/10.1007/s10585-026-10418-w

Related articles

• Impact of neoadjuvant cetuximab on liver function and tumor reduction in a murine model of selective portal vein ligation · Clinical and Experimental Metastasis · 2025 · Same journal
• The challenge of disappearing colorectal liver metastasis: balancing considerations between tumor biology and clinical consequence for liver surgery · Clinical and Experimental Metastasis · 2025 · Same journal
• Gamma knife radiosurgery for cerebellar brain metastases: clinical outcomes and artificial intelligence-based predictive modeling · Clinical and Experimental Metastasis · 2026 · Same journal
• Importance of the timing of combined electrochemotherapy and immunotherapy in the treatment of advanced melanoma · Clinical and Experimental Metastasis · 2025 · Same journal
• FOXM1 expression is induced by the brain microenvironment and supports CRC brain metastatic adaptation · Clinical and Experimental Metastasis · 2026 · Same journal
• CYP4B1 inhibits lung adenocarcinoma metastasis by downregulating slug transcription via Sp1 · Clinical and Experimental Metastasis · 2026 · Same journal
• Prognostic influence of chronic inflammation in patients with head and neck cancer based on sex differences · Clinical and Experimental Metastasis · 2025 · Same journal
• Contribution of tumor-derived extracellular vesicles in the establishment of the pre-metastatic niche: lessons learned from past experimentations and future directions · Clinical and Experimental Metastasis · 2026 · Same journal
• Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinoma · Clinical and Experimental Metastasis · 2025 · Same journal
• Encapsulated histopathological growth pattern of colorectal liver metastases predicts prolonged survival after repeat liver resection for recurrence · Clinical and Experimental Metastasis · 2026 · Same journal